Therapeutic efficacy of chloroquine for the treatment of Plasmodium vivax malaria among outpatients at Hossana Health Care Centre, southern Ethiopia

BACKGROUND: Plasmodium vivax accounts for about 44 % of all malaria infection in Ethiopia. Chloroquine (CQ) is the first-line treatment for vivax malaria in Ethiopia. Chloroquine-resistant (CQR) P. vivax has been emerging in different parts of the world to compromise the efficacy of the drug and pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Assefa, Mesfin, Eshetu, Teferi, Biruksew, Abdissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650862/
https://www.ncbi.nlm.nih.gov/pubmed/26577669
http://dx.doi.org/10.1186/s12936-015-0983-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650862/
https://www.ncbi.nlm.nih.gov/pubmed/26577669
http://dx.doi.org/10.1186/s12936-015-0983-x

Ejemplares similares